The Benjamin Harry Peikin Foundation is providing funding for a comprehensive, collaborative research project between Novartis Pharmaceuticals Corporation and Massachusetts Eye & Ear Infirmary. We aim to understand the root cause of Juvenile Recurrent Respiratory Papillomatosis and our goal is to find a cure through development of an active vaccine targeting the disease's immunology. An active vaccine for Recurrent Respiratory Papillomatosis may lead to a cure for other conditions including prevelent forms of cervical cancer.